140 related articles for article (PubMed ID: 16438895)
1. [Chronomodulated chemotherapy of oxaliplatin, 5-fluorouracil and folinic acid for advanced gastric cancer].
Lu JW; Zhou ZF; Yin BJ; Liu DL; Feng JF; Zhu LJ; Pan LX
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):695-7. PubMed ID: 16438895
[TBL] [Abstract][Full Text] [Related]
2. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.
Lévi FA; Zidani R; Vannetzel JM; Perpoint B; Focan C; Faggiuolo R; Chollet P; Garufi C; Itzhaki M; Dogliotti L
J Natl Cancer Inst; 1994 Nov; 86(21):1608-17. PubMed ID: 7932825
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.
Louvet C; André T; Tigaud JM; Gamelin E; Douillard JY; Brunet R; François E; Jacob JH; Levoir D; Taamma A; Rougier P; Cvitkovic E; de Gramont A
J Clin Oncol; 2002 Dec; 20(23):4543-8. PubMed ID: 12454110
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.
Al-Batran SE; Atmaca A; Hegewisch-Becker S; Jaeger D; Hahnfeld S; Rummel MJ; Seipelt G; Rost A; Orth J; Knuth A; Jaeger E
J Clin Oncol; 2004 Feb; 22(4):658-63. PubMed ID: 14966088
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients.
Garufi C; Bria E; Vanni B; Zappalà AM; Sperduti I; Terzoli E
Br J Cancer; 2003 Nov; 89(10):1870-5. PubMed ID: 14612895
[TBL] [Abstract][Full Text] [Related]
6. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
[TBL] [Abstract][Full Text] [Related]
7. Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient.
Gornet JM; Azoulay D; Lévi F; Yovine A; Misset JL; Goldwasser F
Anticancer Drugs; 2000 Apr; 11(4):263-8. PubMed ID: 10898541
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
[TBL] [Abstract][Full Text] [Related]
9. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer.
Bertheault-Cvitkovic F; Jami A; Ithzaki M; Brummer PD; Brienza S; Adam R; Kunstlinger F; Bismuth H; Misset JL; Lévi F
J Clin Oncol; 1996 Nov; 14(11):2950-8. PubMed ID: 8918492
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of oxaliplatin in combination with continuous infusion of 5-fluorouracil/leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
Hwang WS; Chao TY; Lin SF; Chung CY; Chiu CF; Chang YF; Chen PM; Chiou TJ
Anticancer Drugs; 2008 Mar; 19(3):283-8. PubMed ID: 18510174
[TBL] [Abstract][Full Text] [Related]
11. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer.
Lévi F; Misset JL; Brienza S; Adam R; Metzger G; Itzakhi M; Caussanel JP; Kunstlinger F; Lecouturier S; Descorps-Declère A
Cancer; 1992 Feb; 69(4):893-900. PubMed ID: 1735081
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer.
Curé H; Chevalier V; Adenis A; Tubiana-Mathieu N; Niezgodzki G; Kwiatkowski F; Pezet D; Perpoint B; Coudert B; Focan C; Lévi F; Chipponi J; Chollet P
J Clin Oncol; 2002 Mar; 20(5):1175-81. PubMed ID: 11870158
[TBL] [Abstract][Full Text] [Related]
13. An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial.
Ferrari V; Valcamonico F; Amoroso V; Simoncini E; Vassalli L; Marpicati P; Rangoni G; Grisanti S; Pasinetti N; Marini G
Oncology; 2005; 69(4):283-9. PubMed ID: 16282707
[TBL] [Abstract][Full Text] [Related]
14. [FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].
Yan D; Dai H
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):217-9. PubMed ID: 19615264
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
16. [Palliative surgery combined with oxaliplatin-based chemotherapy in treatment of patients with advanced gastric cancer].
Chen YB; Guan YX; Zhan YQ; Li W; Sun XW; Li YF; Xu DZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1520-2. PubMed ID: 15566671
[TBL] [Abstract][Full Text] [Related]
17. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
Nobili S; Checcacci D; Filippelli F; Del Buono S; Mazzocchi V; Mazzei T; Mini E
J Chemother; 2008 Oct; 20(5):622-31. PubMed ID: 19028627
[TBL] [Abstract][Full Text] [Related]
18. Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients.
Garufi C; Brienza S; Pugliese P; Aschelter AM; Bensmaine ; Bertheault-Cvitkovic F; Nisticò C; Giunta S; Caterino M; Giannarelli D; Cosimelli M; Lévi F; Terzoli E
Anticancer Drugs; 2000 Jul; 11(6):495-501. PubMed ID: 11001391
[TBL] [Abstract][Full Text] [Related]
19. A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy.
Lévi F; Zidani R; Brienza S; Dogliotti L; Perpoint B; Rotarski M; Letourneau Y; Llory JF; Chollet P; Le Rol A; Focan C
Cancer; 1999 Jun; 85(12):2532-40. PubMed ID: 10375099
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group.
Comella P; Lorusso V; Maiorino L; Casaretti R; Cannone M; Massidda B; Putzu C; Leo S; Roselli M; Mancarella S; Palmeri S; Greco E; Vessia G; Sandomenico C; Franco L
Cancer Chemother Pharmacol; 2009 Oct; 64(5):893-9. PubMed ID: 19189106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
